| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 40.45% | Truist Securities | $45 → $40 | Maintains | Buy |
| 09/19/2023 | 58.01% | Truist Securities | → $45 | Reiterates | Buy → Buy |
| 08/08/2023 | 58.01% | Truist Securities | $48 → $45 | Maintains | Buy |
| 08/07/2023 | 12.36% | Stephens & Co. | $37 → $32 | Maintains | Equal-Weight |
| 05/12/2023 | 36.94% | B of A Securities | → $39 | Reinstates | → Buy |
| 04/14/2023 | 15.87% | BMO Capital | → $33 | Reinstates | → Market Perform |
| 03/20/2023 | 43.96% | UBS | $45 → $41 | Maintains | Buy |
| 01/17/2023 | 29.92% | Stephens & Co. | $40 → $37 | Downgrades | Overweight → Equal-Weight |
| 12/14/2022 | 58.01% | UBS | → $45 | Initiates Coverage On | → Buy |
| 10/24/2022 | 22.89% | B of A Securities | $43 → $35 | Maintains | Neutral |
| 10/24/2022 | 8.85% | BMO Capital | $45 → $31 | Downgrades | Outperform → Market Perform |
| 10/07/2022 | 68.54% | Truist Securities | $55 → $48 | Maintains | Buy |
| 08/15/2022 | 50.98% | B of A Securities | $40 → $43 | Downgrades | Buy → Neutral |
| 02/14/2022 | 58.01% | BMO Capital | $52 → $45 | Maintains | Outperform |
| 01/18/2022 | 68.54% | Evercore ISI Group | → $48 | Upgrades | In-Line → Outperform |
| 12/09/2021 | 61.52% | Oppenheimer | → $46 | Initiates Coverage On | → Outperform |
| 11/08/2021 | 110.67% | Truist Securities | $55 → $60 | Maintains | Buy |
| 11/08/2021 | 72.05% | Credit Suisse | $44 → $49 | Maintains | Outperform |
| 08/03/2021 | 50.98% | Goldman Sachs | $39 → $43 | Maintains | Buy |
| 08/03/2021 | 93.12% | Roth Capital | $40 → $55 | Maintains | Buy |
| 07/15/2021 | 58.01% | B of A Securities | → $45 | Initiates Coverage On | → Buy |
| 07/15/2021 | 54.49% | Evercore ISI Group | → $44 | Initiates Coverage On | → In-Line |
| 05/04/2021 | 40.45% | Roth Capital | $43 → $40 | Maintains | Buy |
| 04/30/2021 | 54.49% | Credit Suisse | → $44 | Initiates Coverage On | → Outperform |
| 04/01/2021 | 36.94% | Stephens & Co. | $30 → $39 | Upgrades | Equal-Weight → Overweight |
| 10/19/2020 | -15.73% | Truist Securities | → $24 | Initiates Coverage On | → Buy |
| 08/31/2020 | -36.8% | Jefferies | $16 → $18 | Maintains | Buy |
| 05/20/2020 | -43.82% | Jefferies | $7 → $16 | Upgrades | Hold → Buy |
| 05/05/2020 | -54.35% | BMO Capital | $25 → $13 | Maintains | Outperform |
| 12/26/2019 | -29.78% | Jefferies | $15 → $20 | Maintains | Buy |
| 10/08/2019 | -57.87% | Stephens & Co. | → $12 | Initiates Coverage On | → Equal-Weight |
What is the target price for Green Plains (GPRE)?
The latest price target for Green Plains (NASDAQ: GPRE) was reported by Truist Securities on October 18, 2023. The analyst firm set a price target for $40.00 expecting GPRE to rise to within 12 months (a possible 40.45% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Green Plains (GPRE)?
The latest analyst rating for Green Plains (NASDAQ: GPRE) was provided by Truist Securities, and Green Plains maintained their buy rating.
When is the next analyst rating going to be posted or updated for Green Plains (GPRE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Green Plains, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Green Plains was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
Is the Analyst Rating Green Plains (GPRE) correct?
While ratings are subjective and will change, the latest Green Plains (GPRE) rating was a maintained with a price target of $45.00 to $40.00. The current price Green Plains (GPRE) is trading at is $28.48, which is out of the analyst's predicted range.